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ABSTRACT 
 
Aim: Diabetes Mellitus remains amongst the highest cause of mortality in the world. This study was 
carried out to determine the phytochemical composition of stem bark extracts of Citrus sinensis and 
study their anti-hyperglycaemic activities as well as their modulatory effects on starch and sucrose 
digestion on normal Wistar rats. 
Methodology: Stem bark Aqueous (AqE), Ethanolic (EtE), Hydroethanolic (HEE) extracts of        
C. sinensis were prepared. The content of polyphenols, flavonoids, alkaloids was determined. Anti-
hyperglycaemic activity was evaluated in vivo by oral glucose tolerance test (OGTT) for 120 
minutes. Wistar male rats of 180-200 g were used. After an overnight fast, their glycaemia were 
measured (T0). Rats were then distributed into five groups of six each: Control (water), Tests   
(400 mg/kg of each (AqE, EtE, HEE) extracts), Reference (4 mg/kg B. W., glibenclamide). Thirty 
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minutes later, an overload of 2 g/kg B. W. of glucose was administered to all the groups. Glycaemia 
was measured by tail pricks: 30, 60, 90, 120 minutes after glucose administration. Sucrose           
(2 g/kg B. W.), starch (1 g/kg B. W.) and acarbose in co-administration were used as substrates for 
digestion in a protocol similar to OGTT.  
Results: EtE was very rich in polyphenols (435.56 ± 3.85 µg of eq catechin/mg). Area under the 
Curves, AUC (mg.min.dL-1, P=.05) were: 4015, 786.6, 1163 for PC, AqE group, Reference 
respectively and confirmed that AqE was more efficient than glibenclamide. AqE also showed 
moderate efficacy with sucrose (841.2 vs 1172 mg.min/dL, P=.05) and starch digestion (892.8 vs 
1148; P=.05) compared to positive controls. 
Conclusion: Therefore, stem bark aqueous extract of C. sinensis is able to reduce postprandial 
glycaemia by slowing down the absorption of glucose, challenging the efficacy of glibenclamide,an 
anti-diabetic drug. Also, AqE has moderate efficacy on starch and sucrose digestion. AqE could 
thus be further explored for its potency in the treatment of diabetes mellitus.  
 
 
Keywords: Antihyperglycemia; postprandial glycaemia; stem bark; Citrus sinensis; digestion. 
 
1. INTRODUCTION 
 
The incidence of metabolic syndrome (MS) all 
over the world including Africa is increasing, due 
to a rise in obesity rates among adults [1-2]. 
National Heart and Lung Institute [3] reported 
that in future years, metabolic syndrome may 
overtake smoking as the leading risk factor for 
heart disease. Lifestyle, eating habits, 
sedentarity and urbanization are amongst the 
factors that contribute to its morbi–mortality      
[4,5,6]. MS is defined as a cluster of 
cardiovascular risk factors: dyslipidemia, 
hypertension, abdominal obesity and impaired 
glucose tolerance or diabetes [7]. The common 
manifestation of diabetes include hyperglycemia 
associated or not to insulin resistance. 
Postprandial hyperglycemia is a predisposing 
factor for vascular dysfunction and organ 
damage [8]. It is also associated with long term 
damage, dysfunction, and failure of various 
organs, especially the eyes, kidneys, nerves, 
heart, blood vessels and also an independent 
risk factor for CVD in patients with or without 
diagnosed diabetes [9]. Hyperglycemia or PPHG 
also induces an increase in stiffness of 
intermediate-sized arteries [10,11,12]. PPHG 
produces ROS in oxidative stress involved in 
tissue alteration and disease complications 
associated with the development of diabetic 
nephropathy and retinopathy [13,14]. 
 
Hyperglycaemia or PPHG also arises from food 
digestion. Food is the main and natural source of 
energy with carbohydrates, lipids and proteins 
being the basic nutritive substances. Digestion 
and absorption of food lead to hyperglycemia    
[8-15] followed by a reabsorption period 2–3 
hours later in healthy individuals or longer in 
disease condition [16,17]. 
Amongst the anti-diabetic medications glucagon-
like peptide 1 [GLP-1]  receptor agonists, 
dipeptidylpeptidase -4 [DPP-4] inhibitors have 
significant benefits in reducing post meal plasma 
glucose excursions and lowering HbA1c in 
people with diabetes through inhibition of 
digestive enzymes [11-15-18]. Unfortunately, 
there are many side effects related to these 
medications, amongst which hyperglycemia 
associated to glucocorticoid and corticosteroid 
therapies [19,20,21]. Diabetes treatment and its 
complications present a significant financial 
burden for the budget of every developed country 
[17]. Despite awareness and prevention 
measures taken by governments to control and 
reduce mortality, management of diabetes and 
adequate treatment remain a challenge. The 
current clinical trend is the utilization of naturally 
active compounds as replacement therapies and 
World Health Organization has substantiated 
their utilization for the management of diabetes 
[22,23], due to easy availability, economic 
reasons and lesser side effects [24]. Their use 
has been reported in Guinea [25], in Morocco 
[26] and many other countries.  
 
Citrus sinensis (L.) Osbeck (Sweet Orange) is 
one of the most important and widely grown fruit 
crop.  It accounts for approximately 60% of Citrus 
production for both fresh fruit and processed 
juice consumption. Oranges are an important 
nutritional source for human health and have 
immense economic value [27] for its tasty juice 
and medicinal value [28]. Orange peel extracts 
have been used to treat colic, upset stomach, 
cancer, diuretic and to fight diverse viral and 
bacterial infections [29,30,31]. In addition, only 
orange peel oil extracts and leave oil extracts of 
Citrus sinensis was listed amongst over a 
hundred plants with hypoglycemic and 
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antidiabetic effects reported by Udoamaka and 
Prieto [32]. To date, few or no data on the effect 
of stem bark extracts on acute treatment of 
hyperglycaemia and digestion of carbohydrates 
key substrates have been reported. Therefore, 
this study was conducted to determine the 
phytochemical composition of stem bark extracts 
of Citrus sinensis, study its anti-hyperglycaemic 
activity and the effect on sucrose and starch 
digestion on normal Wistar rats. 
 
2. MATERIALS AND METHODS 
 
2.1 Chemicals 
 
All the chemicals used were of analytical grade 
and were purchased from Sigma Co., Louis, MO, 
USA. These include; Folin- ciocalteu reagent, 
catechin, ethanol, potassium acetate, Quercetin, 
FeCl3; 1, 10-phenanthroline, Acarbose, 
Glibenclamide. 
 
2.2 Plant Materials 
 
Citrus sinensis (L.). Osbeck was harvested in 
February 2016 in Yaounde, city capital of 
Cameroon. It was identified at national herbarium 
with botanical characteristics as described by 
Letouzey et al. [33] as belonging to Rutaceae 
family. Stem bark were isolated, cut into small 
pieces and then shade dried in open air for one 
month. The dried materials were ground to obtain 
powder, from which the different extracts were 
prepared. 
 
2.2.1 Preparation of ethanolic, aqueous, 
hyroethanolic extracts 
 
One hundred grams (100 g) of stem bark were 
placed in 800 mL of ethanol (95%) for 
maceration for 48 hours. After filtration, the 
filtrate was then evaporated at 50°C to obtain the 
ethanolic extracts (EtE). The same procedure 
was followed to prepare aqueous extract (AqE) 
and hydroethanolic extracts (HEtE); ethanol been 
replaced by distilled water and mixture 
water/ethanol (95%) in a ratio of 1:1 (v/v) 
respectively. 
 
2.3 Quantitative Determination of 
Bioactive Compounds 
 
The quantitative analysis of some bioactive 
compounds including polyphenols, flavonoids, 
alkaloids was done. 
 
2.3.1 Determination of polyphenolic content 
 
The polyphenol content was evaluated using the 
method described by Singleton and Rossi [34]. 
Briefly, to 30 µL of the extract, 1 mL of the Folin-
Ciocalteu reagent was added. Thirty minutes 
after the incubation at 25°C, the absorbance was 
read at 750 nm using a spectrophotometer. 
Catechin was used as standard. The total 
polyphenol was expressed in microgram 
equivalence of catechin/mg of extract. 
 
2.3.2 Determination of total flavonoids’ 
content 
 
The total flavonoids content was evaluated using 
the method described by Aiyegoro and Okoh 
[35]. For each extract, 1 mL (1 mg/mL) prepared 
in ethanol solution, 1 mL of aluminium chloride, 
1mL of potassium acetate and 5.6 mL of distilled 
water. The mixture was allowed to stand at 25°C 
for 30 minutes. The absorbance of the reaction 
mixture was read at 420 nm with a 
spectrophotometer. Quercetin was used as the 
standard. The flavonoids content was expressed 
in mg equivalence of quercetin/mg of extract. 
 
2.3.3 Determination of alkaloids’ content 
 
Alkaloid content was evaluated following the 
method reported by Singh et al. [36]. One 
hundred (100 mg) milligrams sample powder was 
mixed with 10 ml of ethanol (80%). The 
supernatant was used for the estimation of total 
alkaloid content. The reaction mixture contained 
1 ml extract, 1 ml of 0.025 M FeCl3 in 0.5 M HCl 
and 1 ml of 0.05 M of 1,10-phenanthroline                   
in ethanol. The mixture was incubated for 30 
minutes using a water bath at the temperature of 
70 ± 2°C. Absorbance of red coloured complex 
developed was read at 510 nm against reagent 
blank. Alkaloid content was expressed as 
microgram equivalence of quinine /mg of extract. 
 
2.4 Animals and Treatments  
 
Sixty six male albinos’ rats weighing 180–200 g 
were obtained from the Laboratory of Animal 
physiology, University of Yaoundé 1, Cameroon. 
Animals were treated according to the ethical 
guidelines outlined in the Guide for Care and Use 
committee of the Institutional ethic committee. All 
protocols were approved by the University of 
Yaounde 1 Animal Ethics Committee. Animals 
were housed under standard conditions in cages; 
25°C, 50-60% relative humidity with 12 h light – 
12 h dark cycle. They were fed with a standard 
diet and received water ad-libitum. All the 
animals were acclimatized for 10 days prior to 
the start of the experiment. 
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2.4.1 Study of anti-hyperglycaemic activity: 
OGTT 
 
Oral Glucose Tolerance Test (OGTT); an in vivo 
acute test was conducted as described by Al-
malki et al. [8], to evaluate the capacity of 
extracts to prevent the absorption and the rise of 
glycaemia. Briefly, thirty (30) rats were randomly 
divided into five groups of six each. After 12 
hours overnight fasting, blood glucose at 
baseline (T0) was measured from vein tails of all 
rats using a glucometer and test strips (One 
touch Gluco-plus). Simultaneously, Group 1 
serving as control group or Positive Control (PC) 
was given water orally. Group 2 received 
Ethanolic Extract (400 mg/kg body weight), 
Group 3 received Aqueous Extract (400 mg/kg 
body weight); Group 4 received Hydroethanolic 
extract (400 mg/kg body weight); Group 5 
received Glibenclamide (4 mg/kg body weight). 
Thirty (30) minutes after administration of 
extracts, animals in all the groups were given 
overload glucose solution (2 g/kg body weight). 
Blood glucose levels were measured using 
glucometer through tail pricks at 30, 60, 90 and 
120 minutes after glucose loading. Administration 
of extracts and glucose was done orally with 
water, 5 mL/kg b. w.  
 
2.4.2 In vivo study of the effects of aqueous 
extract on sucrose and starch digestion 
 
The protocol used was similar to OGTT with 
some modifications. Briefly, animals were 
randomly divided into three groups of six animals 
each. After 12 hours overnight fasting, blood 
glucose at baseline (T0) was measured from vein 
tails of all rats using a glucometer and test strips 
(One touch Gluco-plus). Simultaneously, Group 1 
or Positive Control (PC) was given water + 2 g/kg 
sucrose orally. Group 2 received Aqueous 
Extract (400 mg/kg body weight + 2 g/kg 
sucrose); Group 3 received Acarbose 3 mg/kg B. 
W + 2 g/kg B. W sucrose). Blood glucose levels 
were measured using a glucometer through tail 
pricks at 30, 60, and 120 minutes after sucrose 
loading. A similar design was implemented to 
study starch digestion as described above, 
except that starch 1 g/kg B. W replaced sucrose 
and the follow up was done at 60, 90, 120, 180 
minutes. Administration of extracts and 
substrates (sucrose, starch) was done at the 
same time to allow the interactions between 
extracts, substrates and enzymes in the 
gastrointestinal track. Blood glucose was 
measured as end products from starch and 
sucrose digestion and absorption. 
 
2.5 Data Processing and Analysis 
 
Results were expressed as incremental change 
and as Mean ± Standard Deviation. Graphpad 
prism software, version 6.0 (GraphPad Prism 
INC., CA, USA) was used to determine the area 
under the curve (AUC) as an expression of 
efficacy of extracts. Statistical Package for Social 
Science (SPSS 20.0 Illinois, Chicago) was used 
to analyze results. Paired sample Student-t-test 
was used to analyze blood glucose levels for 
each extract at each time. One-way analysis of 
variance ANOVA test followed by Waller-Dunkan 
as post-hoc was used to compare variables 
between groups under 95% confidence interval. 
 
3. RESULTS AND DISCUSSION 
 
3.1 Results 
 
3.1.1 Phytochemical content 
 
The phytochemical analysis of Citrus sinensis 
stem bark extracts obtained using different soft 
solvent systems; water, ethanol and Water-
ethanol mixture (1:1 v/v) revealed larger 
quantities of polyphenolic compounds in all the 
extracts, the ethanolic extracts being richer than 
the aqueous and hydroethanolic extracts. 
However, hydroethanolic and ethanolic extracts 
possess a higher content of alkaloids. Flavonoids 
were higher in ethanolic extracts (Table 1). 
 
Table 1. Phytochemical content of C. sinensis stem bark extracts 
 
                          Extracts 
Compounds 
Aqueous Hydro ethanolic Ethanolic 
Alkaloids (µg EqQuinine/mg) 4.34  ± 0.6a 13.13 ± 1.6b 13.18 ± 1.6b 
Polyphenols (µg Gallic acid/mg) 208.89 ± 25.24
a
 406.67 ± 57.74
b
 435.56 ± 3.85
b
 
Flavonoids  (µg Eq Quercetin/mg) 0.85 ± 0.05a 1.16 ± 0.15b 9.40 ± 0.70b 
Results expressed as Mean ± SD, Tests were done in triplicates, eq: equivalent; variables with different letters a, 
b, c associated are significantly different P=.05 
 
3.1.2 Anti-hyperglycaemic effects of 
sinensis stem bark extracts
 
Administration of glucose to rats receiving no 
extracts resulted in highest peak at 30 min and 
thereafter a gradual reduction of glycaemic levels 
with time. All other groups showed a peak at 30 
min lower than PC. Values gradually decreased 
during the experiment. It clearly appears that 
aqueous extracts of C. sinensis 
prevent the increase of blood glucose. The 
values were lower compared to positive control, 
and interestingly, lower compared to 
glibenclamide, antidiabetic drug of reference 
(Fig. 1). 
 
3.1.3 Variation of blood glucose in each 
group within two hours experiments
 
With paired-sample Student t test, it is observed 
that acute administration of each extract during 
thirty minutes revealed significant increase of 
82.24% in PC compared to 23.49% in AqE group 
 
Fig. 1. Effect of stem bark extracts on blood glucose level
Results are expressed Mean +/
 
Table 2. Percentage variation within time intervals
Groups Variation 
%variation 
Positive control 82.24 
Glibenclamide 28.13 
EtE 26.42 
HEE 39.35 
AqE 23.49 
Stem bark Aqueous (AqE), Ethanolic (EtE),  Hydroethanolic (HEE) extracts of C. 
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C. 
 
was able to 
 
1 in all the groups except the group receiving 
glibenclamide. The decrease in groups treated
with glibenclamide (-16.07%) and AqE (
was significant after two hours compared to 
baseline Glycaemia (Table 2). 
 
3.1.3 Comparison inter groups at each time 
intervals 
 
An adjustment from glycemic levels at baseline 
showed the trends of each extract in comparison 
with positive control group and with 
glibenclamide, anti-diabetic drug (Fig. 2).
 
Statistical analysis with ANOVA and Waller
Duncan post hoc test revealed that at each time 
interval, there was a significant difference 
between blood glucose increment of PC group 
and all the treated groups and with 
Glibenclamide, reference group. At 60 minutes 
the group receiving AqE significantly decreased 
blood glucose (P=.05) than the group treated 
with glibenclamide (Fig. 2). 
 
 
- SD, n= 5 rats/ group 
 
 
T0 - T30 Variation T30 - T120 Variation (T0
P value %variation P value %variation
<.001 -44.07 .001 1.93 
.093 -34.49 .026 -16.07 
.002 -30.16 .008 -11.71 
.001 -32.38 .001 -5.78 
.006 -36.68 .004 -21.81 
Sinensis
 
 
 
 
 
 
 
 
-21.81%) 
 
-
 
-T120) 
 P value 
.778 
.05 
.06 
.286 
.004 
 
3.1.4 Efficacy of Citrus sinensis extracts
 
The efficacy of each extract measured as AUC 
confirmed that stem bark Aqueous Extract has 
the lowest AUC compared to PC and more 
interestingly to glibenclamide. All other extracts 
showed an AUC lower than Positive Control 
(Fig. 3). 
 
3.1.4 Effects of extract on sucrose digestion
 
Based on results above, Aqueous Extract (AqE) 
being the best antihyperglycaemic extract was 
selected for digestion studies. Administration of 
 
Fig. 2. Effects of C. sinensis stem back extracts on regulation of overload glucose adjusted 
Results expressed as Mean 
 
Fig. 3. Efficacy of stem bark extracts of 
Results expressed as Mean± Standard deviation; n=6 rats/group; 
associated are significantly different P=0.5
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sucrose (only), to rats increased blood glucose 
within 30 min (variation of 13.66 mg/dL).
hour, sucrose was completely digested and 
glucose released, absorbed in PC group. In the 
presence of AqE, there was a delay of 90 
minutes in the digestion/release of glucose from 
sucrose before glucose started subsequently 
appearing in the blood, to reach a peak after 2 
hours (15.33 mg/dL). AqE demonstrated its 
ability to inhibit digestion of sucrose and 
promoted the shift of peak appearance from 30
min with sucrose only (PC) to 120 min in 
presence of AqE (Fig. 4).  
 
from baseline 
± Standard deviation; n=6 rats/group 
 
C. sinensis on overload glucose
bar graphs with different letters a, b, c, d 
 
 
 
 
 
 
 
 
 After an 
 
 
 
 
3.1.5 Efficacy of aqueous extract on sucrose 
digestion 
 
After two hours experiment, the efficacy of AqE 
was lower than positive control as confirmed by 
AUC values. However, acarbose showed highest 
efficacy (Fig. 5). 
 
3.1.6 Effects of aqueous extracts on starch 
digestion 
 
In Fig. 6, It has been observed that in the 
absence of AqE or reference drug, starch is 
digested into its monomers of glucose leading to 
blood glucose rise within an hour to 22.66 mg/dL 
(PC) followed by a consistent digestion and 
absorption all through the experiment.
 
Fig. 4. Effects of aqueous extract on sucrose digestion 
Results were expressed as incremental difference (mg/dL). n=6 rats
 
Fig. 5. Efficacy of 
Results expressed as Mean ± Standard deviation; n=6 rats/group; 
associated are significantly different P=0.5
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With co-administration of AqE, digestion within 
the first hour is similar to PC (P>.05
between 60 to 90 min, digestion of starch is 
slowed down at a rate greater than PC group to 
become constant 90 min.  
 
3.1.7 Efficacy of aqueous extract on starch 
digestion 
 
The efficacy of acarbose (
greater than the efficacy of the group treated
with AqE which had moderate activity compared 
to Positive Control (PC, P=.05). The efficacy 
of AqE was -35% compared to acarbose 
(Fig. 7). 
 
in vivo 
 
 
aqueous extract on sucrose digestion 
bar graphs with different letters a, b, c 
 
 
 
 
 
 
 
 
). But, 
P=.05) was                     
             
               
       
 
 
Fig. 6. Effects of 
Results were expressed as incremental difference (mg/dL). n=6 rats/ groups
 
 
Fig. 7. Efficacy of Aqueous Extract on starch digestion
Results were expressed as mean ± 
different letters a,
 
3.2 Discussion 
 
Metabolic syndrome including obesity and 
diabetes as individual components is the most 
prevailing health concern worldwide and its 
incidence is increasing at a high rate, resulting in 
enormous social costs [2-37]. Control of glycemic 
excursions is an approached to manage MS. 
This study demonstrated the ability of Aqueous 
Ethanolic and Hydroethanolic stem bark extracts 
of C. sinensis to gradually and effectively reduce 
post prandial glycaemia compared to a Pos
Control (Figs. 1,3). It can be speculated that the 
efficacy of the extracts can be helpful in the 
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aqueous extracts on starch digestion 
 
 
 in vivo 
SD. n=6 rats/group; AUC: Area under the Curve, Different histograms 
 b, c associated are significantly different P=0.5 
itive 
prevention and management of diabetes and its 
complications. In this study, Citrus sinensis 
extracts revealed their high content in 
polyphenols, flavonoids and alkaloids (Table 1); 
compounds that could justify the efficacy of 
extracts in reducing blood glucose or preventing 
its increase (Figs. 1, 2, 3). Numerous 
and in vivo animal studies support the beneficial 
effects of dietary flavonoids 
homeostasis for the prevention and treatment of 
obesity and diabetes [38] by regulation of 
carbohydrate digestion, adipose deposition, 
insulin release and glucose uptake in insulin
responsive tissues through numerous cell
 
 
 
 
 
 
 
 
 
in vitro cell 
on glucose 
-
-
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signaling pathways [37]. Flavonoids and 
polyphenols could alleviate chronic 
hyperglycaemia and by so doing prevent insulin 
resistance and oxidative stress found in the 
complex and heterogeneous condition of 
diabetes [39]. Aqueous Extract was the most 
efficacious amongst the extracts (Table 2) 
though its polyphenols, alkaloids, flavonoids 
content was smaller than in EtE and HEE   
(Table 1). Its efficacy was higher compared to 
glibenclamide, an antidiabetic drug used as 
reference (Figs. 2, 3). AqE may be rich in 
bioactive compounds acting via mechanism 
similar to glibenclamide with better effectiveness. 
Glibenclamide, a 5-chloro-N-(2-{4-
[(cyclohexylamino) carbonyl] aminosulfonyl}  
phenyl)ethyl)-2-methoxybenzamide is a second-
generation sulfonylurea that reduces blood 
glucose by binding to the specific receptor for 
sulfonylureas on β-pancreatic cells, blocking the 
inflow of potassium (K
+
) through the ATP-
dependent channel. The resulting increased flow 
of calcium into β-cells causes the contraction of 
the filaments of actomyosin and prompt secretion 
of insulin in large amounts [40,41,42]. Although 
the aqueous extract is just a crude extract, it can 
be speculated that flavanones such as 
naringenin and hesperidin abundant in Citrus 
fruits such as grape, tomatoes and oranges are 
reported to possess antioxidant, anti-diabetic 
properties [43] could be also found in their stem 
bark. In addition, AqE may also reduce glucose 
absorption through interaction with, GLUT2, the 
predominant glucose transporter in the intestine 
[44]. 
 
An indirect appreciation of the aqueous extract 
on invertase an alpha amylase was evaluated on 
the basis of the correlation existing between in 
vitro and in vivo studies on glucose response and 
portal glucose appearance up to 8 h post meal 
[45]. This study revealed that stem bark AqE of 
C. sinensis was able to moderately slow down 
the digestion-absorption process of starch (Figs. 
6 and 7) and sucrose (Figs. 4 and 5) compared 
to PCs. This is result is in accordance with drugs 
used to treat metabolic disease such as obesity / 
diabetes. They act in gastrointestinal tract (GIT) 
to inhibit key enzymes of the digestive system 
including alpha glucosidase, invertase and alpha 
amylase [46,47]. The moderate effects AqE is 
important because in humans, between 40% and 
80% of total caloric intake is accounted for by 
carbohydrates in their various forms making 
them the most important energy source [46]. 
Starch is digested primarily to maltose and other 
short chain carbohydrates by salivary and 
pancreatic amylase [43-46] and postprandial 
glycaemia occurs as a result of absorption of 
monosaccharide mainly glucose. Interference of 
AqE with those enzymes reduces postprandial 
glycaemia. 
 
Sucrose concentration of approximately 1.11 M 
administered in this experiment probably led to 
glucose and fructose appearing in the serosal 
compartment of rats at similar rates of serosal 
transfer as proven ex vivo by Ruth and Leese 
[48]. AqE interfering with sucrose digestion-
absorption was proven to slow down digestion 
and delayed absorption (Fig. 4). Such delay can 
be helpful for the acute treatment of diabetes /or 
of glucose excursions in patients; mainly in 
condition of diabetes where consumption of diet 
with high glycemic index can lead to coma in 
very short period. The delay may also give time 
to hormones and enzymes to be secreted in 
amount higher enough to stimulate the uptake of 
glucose and better promote its plasma clearance 
in normal or diabetic rats, given that the status 
normal or diabetes does not alter the GIT 
functions [49]. 
 
Although the efficacy of AqE was lesser (-35%) 
compared to reference drug acarbose (Fig. 5). It 
can be speculated that aqueous extract of stem 
bark of C. sinensis in its constituents can act 
through inhibition of invertase and alpha 
amylase. In fact, polyphenolic compounds 
present (Table 1) have been shown to possess 
antioxidant actions and to be able to inhibit 
digestive enzymes. Naturally occurring 
polyphenols, in particular catechins and 
condensed tannins isolated from various plant 
sources have been shown to inhibit digestive 
enzymes including lipase and α-amylase in vitro 
[50]. Also, Aq extract may possess molecules 
which could act with mechanisms similar to 
acarbose given that acarbose, C25H43NO18 is a 
pseudo-tetrasaccharide that inhibits intestinal    
α-glucosidase reversibly at the brush border of 
intestinal mucosa. As a consequence, the 
digestion of disaccharides to monosaccharides is 
prevented, the uptake of monosaccharides is 
retarded and thus postprandial insulin and 
glucose levels are reduced [50]. The inhibition of 
the enzymes delays the degradation of 
oligosaccharides to glucose, and therefore 
controls postprandial hyperglycemia [47]. Such 
action mechanism may explain the shift of peaks 
from 30 min to 1 h30 minutes observed on 
sucrose digestion (Fig. 4). Moreover, the faster 
digestion (Fig. 5) of substrate by extracts 
followed by their rapid absorption in acute test 
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(Fig. 2, Table 2) may avoid the gastrointestinal 
side-effects which unfortunately hampered the 
usage of acarbose, despite its good safety record 
[47]. 
 
Flavonoids, polyphenols, alkaloid found in 
Aqueous Extract probably contributed to its 
moderate efficacy on starch digestion and 
inhibition. In fact, black tea polyphenols exert a 
positive effect on inhibiting obesity through two 
major mechanisms: inhibiting lipid and 
saccharide digestion, absorption and intake; thus 
reducing calorie intake [51]. Lochocka et al. [52] 
reported that a single dose of green tea extract 
taken with a test meal decreases starch digestion 
and absorption. Also, Haibo et al. [51] and Hara 
et al. [53] in another study reported that the 
aflavins showed stronger inhibitory effect on GIT 
enzymes than catechins. Such flavonoids mainly 
inhibit only GLUT2 but not SGLT1 [54]. 
 
Many other studies have reported on the use of 
herbs/medicinal plants that interfere with 
carbohydrate digestion and absorption [37-43], 
including a Vietnamese Citrus Peels of 
“Buddha’s hand”, another Rutaceae, whose 
essential oil strongly inhibited α-glucosidase 
activity in a dose dependent manner [47-55].   
 
4. CONCLUSION  
 
Aqueous (AqE), Ethanolic (EtE),  Hydroethanolic 
(HEE) stem bark extracts of C. sinensis with their 
rich phytoconstituents, reduce postprandial 
glycaemia by slowing down absorption of 
glucose. Anti-hyperglycemic efficacy of aqueous 
extract challenges glibenclamide, anti-diabetic 
drug. AqE moderately interferes on starch and 
sucrose digestion. Stem bark AqE of Citrus 
sinensis could thus be further explored for its 
potency in the treatment of diabetes mellitus and 
other metabolic disorders. 
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